Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome.
Plain-language summary
This trial is studying Blood tests and testing of analysis of the lymphoma microenvironment in skin and skin barrier and skin microbiology profile. for people with cutaneous T-cell lymphoma (skin lymphoma). The study measures how well this treatment works and monitors for side effects. This trial does not currently list US sites.
Who can join (key eligibility)
- Age 18 Years to 100 Years years
- Must be well enough for treatment (adequate performance status)
Final eligibility is determined by the trial team. This list is a starting point only.
What's being tested
Blood tests and testing of analysis of the lymphoma microenvironment in skin, skin barrier and skin microbiology profile. (DIAGNOSTIC_TEST): The study aims to perform systematic translational sampling of each patient from study start until end-of-study, or at longest for a three year period for each patient. Treatment will be performed according to clinical routine.
- Drugs / treatments
- Blood tests and testing of analysis of the lymphoma microenvironment in skin, skin barrier and skin microbiology profile.
- Treatment length
- Ask the trial team for details
- Visit frequency
- Ask the trial team for details